PubRank

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

Clinical Trial ID NCT01878617

PubWeight™ 18.35‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01878617

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat Med 2013 2.55
2 Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol 2015 2.02
3 Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2014 1.49
4 Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol 2013 1.12
5 Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 2016 1.11
6 Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin Cancer Res 2014 0.96
7 The rationale for targeted therapies in medulloblastoma. Neuro Oncol 2013 0.92
8 Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors. Cancers (Basel) 2016 0.91
9 Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? Neuro Oncol 2015 0.89
10 Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors. F1000Prime Rep 2014 0.86
11 Targeted treatment for sonic hedgehog-dependent medulloblastoma. Neuro Oncol 2014 0.83
12 Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma. Int J Radiat Oncol Biol Phys 2014 0.80
13 Medulloblastoma development: tumor biology informs treatment decisions. CNS Oncol 2015 0.78
14 Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature. Clin Pharmacokinet 2016 0.76
15 Rare childhood cancers--an increasing entity requiring the need for global consensus and collaboration. Cancer Med 2015 0.76
16 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
17 The impact of molecular analysis on the survival of children with embryonal tumors. Transl Pediatr 2016 0.75
18 Next-generation sequencing of central nervous systems tumors: the future of personalized patient management. Neuro Oncol 2016 0.75
Next 100